Benzinga's Top #PreMarket Losers
September 26, 2014 at 08:08 AM EDT
AcelRx Pharmaceuticals (NASDAQ: ACRX) shares slipped 10.71% to $6.00 in pre-market trading after the company offered a regulatory update ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.